RACGAP1 and hepatocellular carcinoma: Considering hepatocellular carcinoma, RACGAP1 upregulation was significantly associated with the early recurrence of human hepatocellular carcinoma [28], as it activates the RACGAP1/Rho/ERK signaling axis as a competing endogenous RNA to promote early recurrence of hepatocellular carcinoma [29].